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Elucidating endothelial transcriptional response to environmental tobacco smoke is one way to understand the vascular effects of this environmental pollutant. Uncovering dysregulated genes will help to identify the specific pathways and mechanisms of smoke-induced endothelial dysfunction and may lead to improved diagnosis and treatment of its repercussions.
Transcriptional alterations have previously been identified within cultured human umbilical vein endothelial cells exposed to smoke extract, revealing changes in the abundance of mRNAs from genes involved in inflammation, matrix degradation, and proliferation (22) . Also, exposure of cultured endothelial cells to nicotine has been performed and analyzed with gene arrays (29) . However, the levels and kinds of smoke components administered to monocultured endothelium during in vitro exposure may not represent those that occur in vivo, especially when the filtration capacity of the respiratory tract and detoxifying ability of the organismal anti-oxidant system and liver are considered. Moreover, the endothelial response to these toxins may not be the same in cultured cells that have been modified by culture conditions and lack the paracrine and endocrine effects expected in vivo. Therefore, an evaluation of the in vivo transcriptional response to environmental tobacco smoke is necessary to more fully understand the adaptive and pathological responses of endothelium to this toxin.
Here we report the use of a sidestream cigarette smoke exposure model that, as previously demonstrated, can accelerate atherosclerosis (9) . Combining this model with techniques to analyze in vivo endothelial transcriptional responses (20) , we have identified novel transcriptional effects of tobacco smoke within the aortic endothelium.
METHODS AND MATERIALS
Animals. Mice homozygous for the Tie2-green fluorescent protein (GFP) transgene [Tg(TIE2GFP)287Sato; stock no. 003658] were obtained from Jackson Laboratories (Bar Harbor, ME) and bred for these experiments. Males were used at 8-16 wk of age. Controls were siblings of the treated animals. All procedures were approved by the Institutional Animal Care Committees of University of Texas (UT) Southwestern and the University of Kentucky.
Exposure. Mice were exposed to sidestream cigarette smoke as previously described. This system uses the University of Kentucky reference cigarettes, 2R4F, burned in a Heiner-Borgwald device to generate a sidestream cigarette smoke atmosphere for whole body exposure of unrestrained animals in a Hinners chamber adjusted to 34 mg particulates/m 3 with the addition of HEPA-filtered air. Groups of eight mice were exposed for 4 h/day, 5 days/wk, for 1 and 6 wk. This procedure for smoke-exposure has been shown to generate 75-150 ng/ml plasma cotinine and 8-9% carboxyhemoglobin (9) . As controls, groups of age-matched mice were exposed to HEPA-filtered air in the same apparatus. After completion of the last exposure session, smokeexposed and control mice were shipped from the University of Kentucky to UT Southwestern overnight and killed and processed within 24 h of the final exposure period. Two independent groups of experimental and control animals were treated and analyzed after 1 and 6 wk of exposure.
Cell isolation. Animals were euthanized by CO 2 asphyxiation and cervical dislocation. The aortas from the iliac bifurcation to the aortic root were excised by dissection and freed of any adherent tissue. The luminal blood was removed, and the aortas were sliced into 2-mm segments. The aortic segments pooled from 3-4 animals were suspended in 5 ml of Dulbecco's PBS with 2 mg/ml dextrose. The suspension was combined with 5 ml of prewarmed PBS containing 5 mg/ml type II collagenase (Worthington) and deoxyribonuclease (300 U), agitated continuously at 37°C on a shaking platform, and triturated Article published online before print. See web site for date of publication (http://physiolgenomics.physiology.org).
10 times every 10 min for a total digestion period of 40-60 min to generate a single cell suspension. The cell suspension was maintained at 0-4°C throughout the remainder of the isolation, which lasted 2-3 h total. The suspension was combined with 10 ml of 10% FBS in DMEM, and cells were collected by centrifugation and resuspended in 10 ml of PBS. This suspension was then filtered through a sterile 40-m mesh filter to remove undigested tissue fragments. After centrifugation, the pellet was resuspended in 3.5 ml of PBS containing 0.5 mM EDTA, 30 U/ml DNase I, 3% FBS, and 2 mg/ml dextrose. The suspension was once again filtered through a 40-m mesh filter.
Aortic cell suspensions were sorted using a MoFlo from Dako Cytomation (Carpinteria, CA). Cells were excited by a 488-nm laser, and GFP signals were collected via the FL1 channel (510-550 nm). A pressure of up to 30 PSI was employed, generating 5,000-10,000 events/s. Positive cells (500-120,000) were collected directly into 2 ml of TRIzol (Invitrogen).
RNA was extracted according to the manufacturer's protocol, with the addition of 10 g of glycogen added at the RNA precipitation step. One-third of the RNA isolated from cells was then subjected to two cycles of amplification, as described (10), using the Message Amp kit (Ambion, Austin, TX) according to manufacturer's instructions. This produced ϳ30 g of amplified cRNA after two rounds of amplification. Also, a similar amount of the endothelial RNA was amplified into cDNA in a single cycle with the Ovation system (Nugen, San Carlos, CA), used according to the manufacturer's instructions.
It is difficult to assess the integrity of the tiny amounts of RNA obtained from fluorescence-activated cell sorting (FACS)-sorted cells, (no more than 300 ng from the best sort). However, after two rounds of amplification, the cRNA product ultimately generated was considered to be of acceptable molecular size range as determined by agarose gel electrophoresis with ethidium bromide staining (a generally homogeneous smear ranging from 200 bp to 2 kbp).
Probe preparation and array hybridization. Two cycles of linear RNA amplification generated adequate probes for array comparisons. Amplified control and smoke-exposed cRNA (2 g) was directly labeled with Cy3 and Cy5 with the Micromax ASAP RNA Labeling kit (Perkin Elmer) according to the manufacturer's instructions and hybridized overnight to spotted glass oligonucleotide microarrays with two copies of the 13,000 gene murine-long oligo V1 (set 1 and 2; Qiagen, Valencia, CA). Scanning was performed with a Genepix instrument (Axon Instruments, Union City, CA), and Gene Traffic software (Iobion, La Jolla, CA) was used to analyze the data. Average 1-and 6-wk fold changes of microarray features (normalized according to the Lowess subgrid method) were calculated from triplicate hybridizations, which included a single dye reversal.
Real-time PCR confirmation. We designed oligonucleotide amplimers from the cDNA sequences that were predicted to cross an Table 1 . PCR primers The relative expression level for each gene was interpolated from a standard curve generated from a series of cDNA dilutions at cycle times where C T, the threshold intensity, was clearly exceeded. In each real-time PCR run, the abundance of GAPDH and/or cyclophilin A was assessed in parallel, and expression fold changes for genes of interest were calculated by normalization to GAPDH as a loading control. By the microarray analysis, GAPDH mRNA abundance was invariant with 1 or 6 wk of smoke exposure.
The hearts and lungs of smoke-exposed and control mice were collected and rapidly frozen at the time of death, and RNA was extracted from frozen tissues with TRIzol. RNA was pooled from three animals of smoke-exposed or control groups. Real-time PCR analysis of the total heart and lung response to smoke was performed with cDNA derived from 2 g of pooled RNA.
Immunofluorescent localization. Two mice exposed to smoke for 6 wk as well as two 6-wk control mice were killed with subsequent rapid perfusion fixation of the heart and aorta with 4% paraformaldehyde in PBS. These tissues were processed for paraffin thin sections, deparaffinized, and visualized by secondary immunofluorescence using sheep anti-Cfh (ABCAM, Cambridge, MA), the rabbit anti-Cpe N-term described by Y. P. Loh (3), and the rabbit anti-Epxh2 described by B. D. Hammock (5), all at 1:250, along with appropriate Cy3-labeled Donkey anti-sheep and anti-rabbit secondary antibodies (Jackson Immunoresearch) at 1:500.
RESULTS

Microarray and real-time PCR.
Analysis of experiments that employed the murine V1 microarray hybridized to Cy dye-labeled endothelial cRNA of treated vs. control animals revealed 47 transcripts to be dysregulated by Ͼ2.5-fold after either 1 or 6 wk of smoke exposure. The hybridization results are available within the Gene Expression Omnibus database under the accession numbers listed in Table 2 . Thirty-six of these regulated genes identified in the microarray analysis were selected for confirmation by real-time PCR. Of these, 33 (92%) exhibited similar regulation by both methods. These data are graphically presented in Fig. 1 . Seventeen of these genes exhibited Ͼ2.7-fold dysregulation at both of the smoke exposure times.
Of the genes presented in Fig. 1 , Cfh, Epxh2, Cpe, and Calcrl were considered of special interest because of their potential roles in vasoregulation, and were examined in the lung and heart of mice exposed to environmental smoke for 6 wk. These real-time PCR results are presented in Fig. 2 , indicating upregulation of Epxh2, Cfh, and Cpe by Ͼ2.7-fold within the smoke-exposed lung, with lower regulation in the heart. Cardiac Cpe levels were below the threshold level of detection (results not shown).
To confirm the findings shown in Fig. 1 , we examined the aortic expression of Epxh2, Cfh, and Cpe, utilizing immunofluorescent localization to discern any changes occurring with environmental smoke exposure of 6 wk. Immunofluorescent localization with antiserum directed against Epxh2, presented in Fig. 3 , reveals upregulation of this protein after 6 wk of environmental smoke exposure. In results not shown, immunofluorescent localization studies of Cpe revealed its upregulation within the endothelium of the capillary bed of the periaortic fat but not within the aortic luminal endothelium. Also in results not shown, Cfh (a major secreted plasma protein), although strongly localized to endothelium by this method, was not apparently upregulated in the aortic lumen after 6 wk of smoke exposure.
To further confirm the endothelial transcriptional responses to environmental smoke and to study the biological variability in such responses, exposures of mice were duplicated at both 1 and 6 wk. The second set of samples and the original 1-and 6-wk samples of endothelial RNA were amplified with the Nugen Ovation kit, which generates adequate cDNA for realtime analysis in a single round. Real-time PCR for Cpe, Epxh2, Cfh, and Calcrl was then performed with this cDNA. These results are presented in Fig. 4 , revealing consistent and reproducible upregulation of Epxh2 by greater than a single log (2.7-fold). The upregulation of Cpe and Cfh was also concordant with the results presented in Fig. 1 . Calcrl was not reproducibly detected by real-time PCR within both sets of Nugen-amplified cDNA.
DISCUSSION
Changes in transcript abundance occurring within the endothelium in vivo during chronic exposure to smoke are likely to reflect the endothelium's autocrine response to numerous smoke components (CO, nicotine, Ͼ 4,000 others) as well as to secondary smoke metabolites (lipid metabolites, peroxynitrite, etc.) generated by various nonendothelial cells and tissues. Given the pivotal role of the vascular endothelium in maintaining hemostasis and vascular tone, gene regulation in these cells in response to inhalation of tobacco smoke should implicate mechanisms of both toxicity and host response. Our Fig. 2 . Transcriptional responses in whole heart and lung measured using real-time PCR. Bar graph represents natural log of fold regulation in Epxh2, Cfh, Calcrl, and Cpe from mice exposed 6 wk to environmental tobacco smoke. evaluation of the in vivo endothelial transcriptional response to tobacco smoke does indeed identify some of the underlying toxic manifestations of exposure to environmental tobacco smoke within the vasculature.
The acute vascular responses to tobacco smoke have been ascribed to oxidative stress, which can generate reactive oxygen species (ROS) such as superoxide anion (27) These ROS can react with nitric oxide to form peroxynitrite, an uncoupler of the activity of eNOS (15) . Peroxynitrite is also associated with vascular mitochondrial DNA damage and nitration of superoxide dismutase-2 in mice exposed to cigarette smoke at levels comparable with those described here (1, 14) . Thus it has been suggested that rapid loss of the endothelium's ability to generate nitric oxide can help explain acute endothelial dysfunction. Here we demonstrate endothelial adaptive responses that accompany the chronic manifestations of smoke exposure; these include hypertension, increased endothelial adhesiveness, increased vascular permeability, and vascular remodeling.
As shown in Fig. 1 , a number of endothelial genes undergo dysregulation in response to environmental tobacco smoke. These include some with known or potential relevance to vasoregulation, including Epxh2 (epoxide hydrolase-2, or soluble epoxide hydrolase), Cfh (complement factor H, or adrenomedullin binding protein-1), and Calcrl(calcitonin receptor-like). Epxh2 catalyzes the hydrolysis of the endogenous vasorelaxant epoxyeicosatrienoic acid (also known as endothelial-derived hyperpolarizing factor; Ref. 13 ), and we consider its upregulation with smoke exposure to suggest an important role in causing or exacerbating smoke exposure-related hypertension. Cfh, in addition to its established role in regulation of complement activation, has been shown to bind to the vasodilator adrenomedullin and modulate its effects (30) . Calcrl is part of the receptor complex for adrenomedullin and calcitonin gene-related peptide (12) . The finding of two genes highly regulated by smoke exposure, that both impinge on adrenomedulin, strengthens the conclusion that this vasodilatory peptide is involved in vascular responses to smoking. Cpe, or carboxypeptidase E, is a neuroendocrine prohormone convertase with the potential to process atrial natriuretic factor (ANF) (18, 8) and other regulatory peptides. Interestingly, Cpe(Ϫ/Ϫ) null mice exhibit obesity and diabetes (7), and we speculate that upregulation of Cpe may be involved in the weight loss associated with smoking. In results not shown, mice exposed to smoke for 1 and 6 wk weighed 12 and 3% less, respectively, than control mice.
The vasoregulatory changes that occur with smoking are complex. Acute effects of tobacco smoke include hypertension, but paradoxically smokers have lower blood pressure in epidemiological surveys (23) . Cessation of active smoking by an individual does lower blood pressure (21) . Acute experimental exposure to sidestream cigarette smoke increases blood pres- sure and aortic stiffness in humans (19) . Ambulatory blood pressure is higher in children exposed to environmental tobacco smoke (25) . We consider dysregulation of vasoregulatory molecules such as Epxh2, Calcrl, and Cfh to be an important aspect of the complex cardiovascular response to chronic environmental smoke exposure.
The most robust finding presented here is that of a threefold increase in Epxh2 on environmental smoke exposure within FACS-sorted aortic endothelium. This finding was confirmed by localized upregulation of Epxh2 protein in the aorta on smoke exposure. Increased Epxh2 levels in response to smoking are consistent with recent published reports of the key role of Epxh2 in vasoregulation. Studies of Epxh2 inhibitors used as a means of decreasing experimental hypertension (13, 17) and studies of gene polymorphisms in rats (6) and humans (26) all indicate that even small alterations in Epxh2 activity may affect vascular tone. We speculate that therapies that inhibit Epxh2 might be particularly efficacious in the treatment of hypertension in patients who smoke.
